A new nonopioid pain reliever could be welcome news for people who have difficult-to-treat back pain. Tanezumab is what's called a monoclonal antibody. And it might offer extended relief from chronic lower back pain, a large, new study finds.However, a serious side effect remains a concern.
Source: WebMD
